Beta Bionics, Inc. (BBNX) Non-Current Deffered Revenue (2023 - 2026)

Beta Bionics (BBNX) has 4 years of Non-Current Deffered Revenue data on file, last reported at $3.4 million in Q1 2026.

• Quarterly Non-Current Deffered Revenue rose 43.78% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 43.78% YoY) and the FY2025 annual result came in at $3.3 million, up 77.26% from the prior year.
• Non-Current Deffered Revenue improved to $3.4 million in Q1 2026 per BBNX's latest filing, from $3.3 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $3.4 million in Q1 2026, with the low at $255000.0 in Q4 2023.
• Average Non-Current Deffered Revenue over 4 years is $2.4 million, with a median of $2.7 million recorded in 2025.
• Year-over-year, Non-Current Deffered Revenue surged 629.41% in 2024 and surged 43.78% in 2026.
• Beta Bionics' Non-Current Deffered Revenue stood at $255000.0 in 2023, then surged by 629.41% to $1.9 million in 2024, then surged by 77.26% to $3.3 million in 2025, then climbed by 1.61% to $3.4 million in 2026.
• Business Quant data shows BBNX's Non-Current Deffered Revenue at $3.4 million in Q1 2026, $3.3 million in Q4 2025, and $3.0 million in Q3 2025.